Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot Israel

Showing results (121-130 of 322) with videos related to

Pageof 33
Sort By:
Allergy|August 7, 2024
Transcriptomic profiles of well-differentiated airway epithelial cells in response to environmental triggers of asthma exacerbationAntonella Marrocco, Jennifer A Mitchel, Margaret Parker, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2015
Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory diseaseKathleen M Buchheit, Katherine N Cahill, Howard R Katz, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
An Adipo-Pulmonary Axis Mediated by FABP4 Hormone Defines a Therapeutic Target Against Obesity-Induced Airway DiseaseM Furkan Burak, Gurol Tuncman, Ayse Nur Ayci, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 8, 2014
Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPDDirkje S Postma, Nicolas Roche, Gene Colice, et al.
Journal of Asthma and Allergy|June 14, 2022
Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled TrialLavinia Davidescu, Grigoriy Ursol, Oleksii Korzh, et al.
ERJ Open Research|October 13, 2016
Add-on LABA in a separate inhaler as asthma step-up therapy <i>versus</i> increased dose of ICS or ICS/LABA combination inhalerDavid B Price, Gene Colice, Elliot Israel, et al.
Immunotherapy|September 29, 2023
Tezepelumab for the treatment of severe asthma: a plain language summary of the PATHWAY and NAVIGATOR studiesJonathan Corren, Andrew Menzies-Gow, Johan Bimmel, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2022
Clinical and molecular implications of RGS2 promoter genetic variation in severe asthmaJuan Carlos Cardet, Donghwa Kim, Eugene R Bleecker, et al.
Chest|October 11, 2016
Association Between Insomnia and Asthma Burden in the Severe Asthma Research Program (SARP) IIIFaith S Luyster, Patrick J Strollo, Fernando Holguin, et al.
Nature Medicine|December 17, 2013
Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivityHye Young Kim, Hyun Jun Lee, Ya-Jen Chang, et al.
Pageof 33

Showing results (121-130 of 322) with videos related to

Sort By:
Pageof 33
Allergy|August 7, 2024
Transcriptomic profiles of well-differentiated airway epithelial cells in response to environmental triggers of asthma exacerbationAntonella Marrocco, Jennifer A Mitchel, Margaret Parker, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2015
Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory diseaseKathleen M Buchheit, Katherine N Cahill, Howard R Katz, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
An Adipo-Pulmonary Axis Mediated by FABP4 Hormone Defines a Therapeutic Target Against Obesity-Induced Airway DiseaseM Furkan Burak, Gurol Tuncman, Ayse Nur Ayci, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 8, 2014
Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPDDirkje S Postma, Nicolas Roche, Gene Colice, et al.
Journal of Asthma and Allergy|June 14, 2022
Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled TrialLavinia Davidescu, Grigoriy Ursol, Oleksii Korzh, et al.
ERJ Open Research|October 13, 2016
Add-on LABA in a separate inhaler as asthma step-up therapy <i>versus</i> increased dose of ICS or ICS/LABA combination inhalerDavid B Price, Gene Colice, Elliot Israel, et al.
Immunotherapy|September 29, 2023
Tezepelumab for the treatment of severe asthma: a plain language summary of the PATHWAY and NAVIGATOR studiesJonathan Corren, Andrew Menzies-Gow, Johan Bimmel, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2022
Clinical and molecular implications of RGS2 promoter genetic variation in severe asthmaJuan Carlos Cardet, Donghwa Kim, Eugene R Bleecker, et al.
Chest|October 11, 2016
Association Between Insomnia and Asthma Burden in the Severe Asthma Research Program (SARP) IIIFaith S Luyster, Patrick J Strollo, Fernando Holguin, et al.
Nature Medicine|December 17, 2013
Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivityHye Young Kim, Hyun Jun Lee, Ya-Jen Chang, et al.
Pageof 33